Roles of the tissue-type plasminogen activator in immune response.


Journal

Cellular immunology
ISSN: 1090-2163
Titre abrégé: Cell Immunol
Pays: Netherlands
ID NLM: 1246405

Informations de publication

Date de publication:
01 2022
Historique:
received: 20 08 2021
revised: 06 10 2021
accepted: 29 10 2021
pubmed: 16 11 2021
medline: 27 1 2022
entrez: 15 11 2021
Statut: ppublish

Résumé

The COVID-19 pandemic has once again brought to the forefront the existence of a tight link between the coagulation/fibrinolytic system and the immunologic processes. Tissue-type plasminogen activator (tPA) is a serine protease with a key role in fibrinolysis by converting plasminogen into plasmin that can finally degrade fibrin clots. tPA is released in the blood by endothelial cells and hepatocytes but is also produced by various types of immune cells including T cells and monocytes. Beyond its role on hemostasis, tPA is also a potent modulator of inflammation and is involved in the regulation of several inflammatory diseases. Here, after a brief description of tPA structure, we review its new functions in adaptive immunity focusing on T cells and antigen presenting cells. We intend to synthesize the recent knowledge on proteolysis- and receptor-mediated effects of tPA on immune response in physiological and pathological context.

Identifiants

pubmed: 34781155
pii: S0008-8749(21)00170-2
doi: 10.1016/j.cellimm.2021.104451
pmc: PMC8577548
pii:
doi:

Substances chimiques

Tissue Plasminogen Activator EC 3.4.21.68

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

104451

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Références

PLoS One. 2015 Jul 01;10(7):e0131216
pubmed: 26132730
Am J Clin Exp Immunol. 2014 Feb 27;3(1):30-6
pubmed: 24660119
J Leukoc Biol. 2020 Jan;107(1):145-158
pubmed: 31667914
J Dermatol Sci. 2010 Jul;59(1):25-30
pubmed: 20494554
EMBO J. 2004 Oct 1;23(19):3793-802
pubmed: 15372073
Proc Natl Acad Sci U S A. 2018 Nov 6;115(45):11585-11590
pubmed: 30348790
J Autoimmun. 2014 Aug;52:36-43
pubmed: 24423642
Annu Rev Pathol. 2020 Jan 24;15:123-147
pubmed: 31530089
Cell Mol Life Sci. 2006 Mar;63(6):709-22
pubmed: 16465451
J Cereb Blood Flow Metab. 2011 Nov;31(11):2119-34
pubmed: 21878948
eNeuro. 2018 Aug 6;5(4):
pubmed: 30090852
J Neurochem. 2006 Sep;98(5):1458-64
pubmed: 16800849
Nature. 1983 Jan 20;301(5897):214-21
pubmed: 6337343
Am J Pathol. 2009 Feb;174(2):586-94
pubmed: 19147818
J Neurosci. 2003 Apr 15;23(8):3234-42
pubmed: 12716930
Am J Pathol. 1994 May;144(5):855-61
pubmed: 8178936
Mol Neurobiol. 2016 Sep;53(7):5000-12
pubmed: 26377106
Clin Immunol. 2014 May-Jun;152(1-2):90-100
pubmed: 24650778
F1000Prime Rep. 2014 Mar 03;6:13
pubmed: 24669294
Sci Rep. 2014 Feb 20;4:4146
pubmed: 24553452
J Immunol. 2008 Sep 1;181(5):3567-74
pubmed: 18714030
Thromb Haemost. 2007 Mar;97(3):394-9
pubmed: 17334506
Cell Immunol. 2020 Feb;348:104040
pubmed: 31955841
Int J Mol Sci. 2021 Feb 08;22(4):
pubmed: 33567773
Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1495-504
pubmed: 24764453
J Am Soc Nephrol. 2012 Aug;23(8):1329-38
pubmed: 22677557
J Exp Med. 2011 Jun 6;208(6):1229-42
pubmed: 21576385
Biochim Biophys Acta. 2016 Mar;1862(3):395-402
pubmed: 26493446
Semin Immunol. 2019 Aug;44:101335
pubmed: 31734129
J Immunol. 2013 Oct 1;191(7):3681-93
pubmed: 23997225
J Immunol. 2006 Dec 1;177(11):8171-6
pubmed: 17114493
J Neurosci. 2020 Feb 19;40(8):1778-1787
pubmed: 31953371
Blood. 1996 May 15;87(10):4204-13
pubmed: 8639779
Arterioscler Thromb Vasc Biol. 2008 Oct;28(10):1844-50
pubmed: 18617644
Nat Immunol. 2005 Sep;6(9):895-901
pubmed: 16116469
Am J Pathol. 2005 Aug;167(2):545-54
pubmed: 16049338
Nat Immunol. 2006 Oct;7(10):1101-8
pubmed: 16964261
Thromb Haemost. 1997 Jun;77(6):1168-73
pubmed: 9241752
Blood. 2017 May 25;129(21):2896-2907
pubmed: 28320709
Acta Biochim Biophys Sin (Shanghai). 2013 Jul;45(7):593-600
pubmed: 23681234
Kidney Int. 1996 Apr;49(4):1097-104
pubmed: 8691730
Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):582-90
pubmed: 20056908
J Biol Chem. 2002 Sep 6;277(36):33509-17
pubmed: 12093796
Front Immunol. 2015 Nov 19;6:571
pubmed: 26635790
FEBS Lett. 1985 Sep 9;189(1):145-9
pubmed: 3896853
Immunol Cell Biol. 2016 Nov;94(10):955-963
pubmed: 27301418
Blood. 2017 Jul 6;130(1):59-72
pubmed: 28325863
Blood. 1989 Sep;74(4):1222-5
pubmed: 2504304
Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):1369-74
pubmed: 26787872
Br J Pharmacol. 2002 Jan;135(1):284-92
pubmed: 11786505
J Exp Med. 2002 Jan 7;195(1):15-21
pubmed: 11781361
J Exp Med. 2020 Apr 6;217(4):
pubmed: 32159743
J Neurochem. 2010 Apr;113(2):447-53
pubmed: 20085611
Oncotarget. 2017 Oct 4;8(50):88094-88103
pubmed: 29152144
Biochem Biophys Res Commun. 2006 Mar 10;341(2):299-303
pubmed: 16413499
J Cereb Blood Flow Metab. 2008 Jun;28(6):1212-21
pubmed: 18334994
J Leukoc Biol. 2015 Apr;97(4):699-710
pubmed: 25670787
Cell Signal. 2020 Nov;75:109761
pubmed: 32861744
Thromb Haemost. 2014 Aug;112(2):243-54
pubmed: 24718307
J Neurosci. 2012 Apr 11;32(15):5186-99
pubmed: 22496564
Am J Respir Cell Mol Biol. 2011 May;44(5):700-8
pubmed: 20639459
Exp Mol Med. 2003 Dec 31;35(6):578-85
pubmed: 14749538
Blood. 2010 Feb 18;115(7):1319-30
pubmed: 19897580
J Neuroinflammation. 2021 Feb 20;18(1):52
pubmed: 33610187
J Thromb Haemost. 2013 Mar;11(3):539-46
pubmed: 23301636
Nat Med. 2003 Oct;9(10):1313-7
pubmed: 12960961
J Leukoc Biol. 2019 Apr;105(4):729-740
pubmed: 30690783
Blood. 2001 Jun 15;97(12):3941-50
pubmed: 11389038
Am J Pathol. 2001 Dec;159(6):2227-37
pubmed: 11733372
Blood. 2017 Sep 14;130(11):1364-1374
pubmed: 28684538
Biochem J. 1996 Feb 1;313 ( Pt 3):775-80
pubmed: 8611154
J Biol Chem. 1982 Mar 25;257(6):2912-9
pubmed: 7199524
Brain. 2016 Sep;139(Pt 9):2406-19
pubmed: 27435092
Nat Med. 2001 Jan;7(1):59-64
pubmed: 11135617
Blood. 2019 Feb 14;133(7):743-753
pubmed: 30504459
EMBO J. 2006 May 3;25(9):1860-70
pubmed: 16601674
Cell Death Dis. 2015 Oct 15;6:e1924
pubmed: 26469972
J Immunol. 2006 May 1;176(9):5153-9
pubmed: 16621978
J Immunol. 1999 Jan 15;162(2):1032-41
pubmed: 9916730
J Neurosci. 2002 Dec 15;22(24):10781-9
pubmed: 12486171
Blood. 2009 Oct 8;114(15):3352-8
pubmed: 19608750
Exp Mol Pathol. 2010 Apr;88(2):278-86
pubmed: 20079732
J Biol Chem. 2015 Mar 20;290(12):7910-7
pubmed: 25670857
PLoS One. 2016 Jul 18;11(7):e0158653
pubmed: 27427941
PLoS One. 2019 Nov 7;14(11):e0224738
pubmed: 31697716

Auteurs

Célia Seillier (C)

Normandie Univ, UNICAEN, INSERM, GIP Cyceron, Institut Blood and Brain @Caen-Normandie (BB@C), UMR-S U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Caen, France.

Pauline Hélie (P)

Normandie Univ, UNICAEN, INSERM, GIP Cyceron, Institut Blood and Brain @Caen-Normandie (BB@C), UMR-S U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Caen, France.

Gautier Petit (G)

Normandie Univ, UNICAEN, INSERM, GIP Cyceron, Institut Blood and Brain @Caen-Normandie (BB@C), UMR-S U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Caen, France; Department of Immunology and Histocompatibility (HLA), Caen University Hospital, CHU Caen, France.

Denis Vivien (D)

Normandie Univ, UNICAEN, INSERM, GIP Cyceron, Institut Blood and Brain @Caen-Normandie (BB@C), UMR-S U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Caen, France; Department of Clinical Research, Caen University Hospital, CHU Caen, France.

Diego Clemente (D)

Grupo de Neuroinmuno-Reparación, Hospital Nacional de Parapléjicos, Finca La Peraleda s/n, 45071 Toledo, Spain.

Brigitte Le Mauff (B)

Normandie Univ, UNICAEN, INSERM, GIP Cyceron, Institut Blood and Brain @Caen-Normandie (BB@C), UMR-S U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Caen, France; Department of Immunology and Histocompatibility (HLA), Caen University Hospital, CHU Caen, France.

Fabian Docagne (F)

Normandie Univ, UNICAEN, INSERM, GIP Cyceron, Institut Blood and Brain @Caen-Normandie (BB@C), UMR-S U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Caen, France.

Olivier Toutirais (O)

Normandie Univ, UNICAEN, INSERM, GIP Cyceron, Institut Blood and Brain @Caen-Normandie (BB@C), UMR-S U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), Caen, France; Department of Immunology and Histocompatibility (HLA), Caen University Hospital, CHU Caen, France. Electronic address: toutirais-o@chu-caen.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH